Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review
Paul Elsbernd, William R. Hoffman, Jonathan L. Carter, Dean M. Wingerchuk
Topics & Concepts
MedicineTocilizumabMultiple sclerosisDermatologyImmunologyRheumatoid arthritisMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAutoimmune Neurological Disorders and Treatments